News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Deaths Prompt Revisions in Japanese Precautions for Boehringer Ingelheim Corporation's Prazaxa


8/15/2011 8:23:52 AM

Boehringer Ingelheim has strengthened the safety warnings and use precautions for its novel anticoagulant Prazaxa (dabigatran etexilate) in Japan following the deaths of five patients receiving the product. The oral direct thrombin inhibitor, marketed as Pradaxa elsewhere, was the first in the...

Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES